VTE in Maternal Mortality: ThrombUS+ Horizon Europe Project and Elvira Grandone
“Maternal death during pregnancy, childbirth, or the postpartum period remains a major tragedy for families and communities. Although less than 1% of global maternal deaths occur in high-income countries, it is estimated that approximately 50% of these deaths are potentially preventable.
In line with the Sustainable Development Goals (2016–2030), European countries are also called to action to eliminate avoidable maternal and neonatal deaths. A critical first step is the improvement of data monitoring and reporting, ensuring that no maternal, fetal, or neonatal death goes unnoticed.
Recent data from the Italian Obstetric Surveillance System (ItOSS) revealed significant geographic disparities in maternal mortality across Italy, with higher rates in Southern regions (10.5 per 100,000 live births) compared to the North (7.7) and Center (5.9).
Among maternal deaths occurring within 42 days postpartum, direct obstetric causes accounted for 55.1%, with obstetric hemorrhage being the leading cause (37.1%), followed by sepsis (13.9%), hypertensive disorders (13.4%), and notably, venous thromboembolism (VTE) at 11.9%.
These findings highlight the urgent need for enhanced prevention, early recognition, and management of VTE, a still under-recognized but significant contributor to maternal mortality in Italy.
Data from ItOSS – Italian Obstetric Surveillance System
Data from Elvira Grandone, Ospedale Casa Sollievo della Sofferenza”
Stay informed with Hemostasis Today.
-
Nov 4, 2025, 09:26Courtney Lawrence: One of Our Most Popular American Red Cross SUCCESS Talks is Just Around the Corner!
-
Nov 4, 2025, 09:21New Study by Emmanuel J Favaloro and Team Questions Consistency in APS Classification and Diagnosis
-
Nov 4, 2025, 09:20Yazan Abou Ismail to Present Insights on AI Models in TTP at 67th ASH Annual Meeting
-
Nov 4, 2025, 09:17David Calvet Canut on Takeda's HyHub: A Shift Toward Patient-Centered Biologics
-
Nov 4, 2025, 09:16Samantha Nelson Encourages You to Share Your Experience on World Thrombosis Day
-
Nov 4, 2025, 08:57Toluwalase Awoyemi: Digital Health Meets Maternal Heart Care
-
Nov 4, 2025, 08:53Rebecca Ahrens Nicklas Shares FDA Interactions on Interventional Genetics with The Rare Disease Community
-
Nov 3, 2025, 09:13Claudio Carrubba on How Timing Truly Matters in Trauma Embolization
-
Nov 3, 2025, 08:57Multiplex Apolipoprotein Panel Boosts Cardiovascular Risk Prediction and Precision Therapy
-
Nov 3, 2025, 08:46Rachel Lamerton and Colleagues on Activation of Platelets in Flow Cytometry
-
Nov 4, 2025, 09:10OCCUPI Trial Analysis Highlights Benefits of OCT Guidance in ACS Patients
-
Oct 29, 2025, 07:31The Use of Artificial Intelligence to Improve Detection of Acute Incidental Pulmonary Emboli - JTH
-
Oct 29, 2025, 07:05Shrinidhi Nathany: AI in Diagnostic Medicine
-
Oct 28, 2025, 07:02Aya Berman: AI Model for Predicting Bacteremia
-
Oct 28, 2025, 06:55The New Era of Genomics, AI and Cell Therapy in Hematology and Infectious Diseases
-
Nov 4, 2025, 09:17HaemophiliaIRL Series Begins․ Advances in von Willebrand Disease Treatment
-
Nov 4, 2025, 09:14Exploring Molecular Pathways of Aging in Hematopoiesis․ FEBS Workshop 2025
-
Nov 4, 2025, 08:28Fritz Roth Thanks Supporters of Science Magazine Study Linking Genes to High Cholesterol and Heart Attack Risk
-
Nov 4, 2025, 08:22Colleen Silk on Novo Nordisk Taking the 2025 Prix Galien US Award
-
Nov 4, 2025, 08:14Cristina Anton: Excited to Be Part of Women in Hematology!